Explain me topics like introduction to dermatology and layers of skin, epidermal cells, introduction to common skin conditions, adnexal disorders, melanin disorders, skin cancers, facial skin lesions, alopecia, mast cell disorders, woods lamp examination, miscellaneous inflammatory dermatoses, dermoepidermal junction and direct immunofluorescence, scalp hair cycle, nail diseases, cutaneous tb and erythema nodosum, drug reactions topics from dermatology mbbs from standard textbook only for neet pg and inicet preparation 2026

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

These are your complete, exam-focused NEET PG / INI-CET 2026 Dermatology notes. Here's a summary of what was covered:

What's Covered (All 17 Topics):

Introduction to Dermatology — skin functions, structure, three layers
Layers of Skin — CBSGS mnemonic for epidermal layers, dermis (papillary vs reticular), hypodermis, collagen types
Epidermal Cells — Keratinocytes, Melanocytes (1:36 ratio, epidermal melanin unit), Langerhans cells (Birbeck granules, CD1a, CD207), Merkel cells (CK20)
Common Skin Conditions — Primary vs secondary morphology, psoriasis (Munro microabscess, Kogoj pustule, Auspitz sign), eczema (spongiosis, IgE, Th2)
Adnexal Disorders — Holocrine sebaceous glands, eccrine (miliaria, hyperhidrosis), apocrine (Fox-Fordyce, hidradenitis suppurativa)
Melanin Disorders — Melasma, vitiligo (JAK inhibitors), albinism, pityriasis versicolor (spaghetti & meatballs), leprosy, café-au-lait macules
Skin Cancers — BCC (peripheral palisading, PTCH1/Gorlin), SCC (Marjolin, Bowen's), Melanoma (ABCDE, Breslow, subtypes, BRAF V600E, immunotherapy), Merkel cell carcinoma
Facial Skin Lesions — Acne vulgaris (isotretinoin, iPLEDGE), Rosacea (rhinophyma, Demodex), xanthelasma
Alopecia — AGA (DHT, finasteride), Alopecia areata (swarm of bees, JAK inhibitors, exclamation mark hairs), Telogen effluvium, Tinea capitis, Scarring alopecias
Mast Cell Disorders — Mastocytosis, Darier's sign, D816V KIT mutation, CD117+/CD2+/CD25+, tryptase
Wood's Lamp — Coral-pink (erythrasma), Green (Microsporum), White (vitiligo), Golden-yellow (tinea versicolor), Blue-white (ash-leaf macule)
Inflammatory Dermatoses — Lichen planus (6 P's, Wickham's striae, HCV, lichenoid reactions), Pityriasis rosea (Herald patch, HHV-6/7), Urticaria, Bullous diseases (DIF patterns table)
DEJ & Direct Immunofluorescence — 4 BMZ layers, hemidesmosomes, Epidermolysis bullosa types, all DIF patterns with diseases
Scalp Hair Cycle — Anagen/Catagen/Telogen durations and percentages, bulge stem cells, lanugo/vellus/terminal, anagen vs telogen effluvium
Nail Diseases — Complete nail signs with associations, onychomycosis (terbinafine), paronychia, green nail syndrome
Cutaneous TB & Erythema Nodosum — All TB types (lupus vulgaris = apple-jelly, scrofuloderma, TBVC), tuberculids, EN (Löfgren's syndrome, septal panniculitis, SSTRIPE causes)
Drug Reactions — SJS/TEN (SCORTEN, HLA associations), DRESS (HHV-6, 2–8 week latency), FDE, morbilliform, photosensitivity, and drug-specific skin reactions table

Explain hansens disease from standard textbooks of dermatology for neet pg and inicet with pyq included

Reading File

Finding Sources

Searching the Web

Hansen's disease leprosy NEET PG previous year questions dermatology 2023 2024 2025

Reading File

Reading Web Page

leprosy MCQ NEET PG answers classification reactions treatment

Reading File

Excellent content gathered. Now I have comprehensive material from both Andrews' Clinical Dermatology and Robbins Pathology. Let me compile the complete notes now:

🦠 HANSEN'S DISEASE (LEPROSY) — Complete NEET PG / INI-CET 2026 Notes

Sources: Andrews' Diseases of the Skin — Clinical Dermatology | Robbins, Cotran & Kumar — Pathologic Basis of Disease | Roitt's Essential Immunology | Sherris Medical Microbiology

1. INTRODUCTION & EPIDEMIOLOGY

Hansen's disease = chronic granulomatous infection caused by Mycobacterium leprae (and rarely M. lepromatosis, proposed 2008)
Obligate intracellular pathogen — infects dermal macrophages and Schwann cells
Cannot be cultured in vitro (only in armadillo foot pads and mouse foot pads)
Grows optimally at 32–34°C → prefers cooler tissues: skin, peripheral nerves, anterior eye, testes, upper airway
Does NOT affect CNS, liver parenchyma, or bones directly (core temperature too high)
Incubation period: 2–5 years (tuberculoid); 8–12 years (lepromatous) — longest incubation of any bacterial infection
Global burden: ~200,000 new cases/year; endemic in India, Brazil, Indonesia, SE Asia, Africa
India: elimination target <1/10,000; current prevalence ~0.45/10,000

Transmission

Respiratory droplets (nasal secretions of LL patients) — primary route
Skin-to-skin contact (prolonged close contact)
Zoonotic reservoir: Nine-banded armadillo (Dasypus novemcinctus) — in southern USA
NOT highly contagious — 95% of humans are naturally immune

2. MICROBIOLOGY OF M. LEPRAE

Feature	Detail
Type	Gram-positive, acid-fast bacillus (AFB)
Shape	Rod-shaped, arranged in "cigar bundles" (globi)
Culture	Cannot be cultured in vitro
Animal model	Armadillo, nude mouse footpad
Virulence factor	PGL-1 (phenolic glycolipid-1) — essential for host cell invasion
Immune evasion	Inhibits mitochondrial energy metabolism; downregulates MHC
BCG cross-protection	Yes — BCG confers ~50% protection
Staining	Fite-Faraco stain (for tissue); Ziehl-Neelsen stain
Replication time	13 days (slowest of all bacteria)

NEET Key: M. leprae has the longest doubling time of any bacterium (~13 days). Cannot be cultured on artificial media.

3. IMMUNOLOGY — THE SPECTRUM CONCEPT (RIDLEY-JOPLING)

The form of leprosy depends entirely on host cell-mediated immunity (CMI):

HIGH CMI ←————————————————————————————→ LOW CMI
   TT        BT        BB        BL        LL
(Tuberculoid)              (Lepromatous)

Feature	Tuberculoid (TT)	Lepromatous (LL)
Immune response	Strong Th1 (IL-2, IFN-γ, IL-12, Th17)	Weak Th1; Th2 dominant (IL-4, IL-5, IL-10); ↑ T-reg cells
Macrophage type	M1 (classically activated)	M2 (alternatively activated); lepra cells
Bacteriology	Paucibacillary (few/no bacilli)	Multibacillary (numerous bacilli, globi)
Lepromin test	Strongly positive	Negative
Antibody (anti-PGL-1)	Low	High (not protective)
Immune complexes	No	Yes → ENL, vasculitis, glomerulonephritis
Histology	Well-formed epithelioid granulomas; no bacilli	Foamy (lepra) cells; abundant globi; no/few lymphocytes

4. CLASSIFICATION

A. Ridley-Jopling Classification (Standard/International)

Type	Abbreviation	Lesions	Bacilli	Lepromin
Tuberculoid	TT	1–3; well-defined	0	+++
Borderline Tuberculoid	BT	Few; defined edges	Rare	+
Mid-Borderline	BB	Several; "punched out"	+	±
Borderline Lepromatous	BL	Many; poorly defined	++	−
Lepromatous	LL	Diffuse; symmetric	+++	−

B. WHO Classification (used for MDT regimen selection — NEET Favourite)

Type	Skin Smear	Lesion Count	Regimen
Paucibacillary (PB)	Negative	≤5 lesions	6 months
Multibacillary (MB)	Positive	>5 lesions	12 months

NEET Key: WHO PB = ≤5 lesions; MB = >5 lesions. Smear positivity alone = MB regardless of lesion count.

C. Indian Classification (IAL — used in Indian textbooks)

Indeterminate (I) → Tuberculoid (T) → Borderline (B) → Lepromatous (L)

5. CLINICAL FEATURES

Indeterminate Leprosy

Earliest form; often the first clinical sign
Solitary, poorly defined hypopigmented macule on cheek, upper arm, thigh, buttock
Sensory changes minimal or absent; no nerve enlargement; no nodules
Histology: lymphocytic infiltrate without granulomas; few or no bacilli
May spontaneously resolve (if CMI strong) or evolve into TT, BB, or LL
Diagnosis is not indeterminate — the classification is indeterminate

Tuberculoid Leprosy (TT)

1–5 lesions, asymmetrically distributed
Typical lesion: Large erythematous plaque; sharply elevated, indurated border sloping to a flattened atrophic center → "saucer right side up"
Dry, scaly, hairless (anhidrotic), anesthetic
Cardinal signs: Anesthesia + Anhidrosis + Alopecia within the lesion
Enlarged peripheral nerves near the lesion → tender, cord-like
"Feeding nerve" = enlarged nerve leading to the lesion (in BT especially)
Common sites: face, limbs, trunk; NOT scalp, axillae, groin, perineum (these areas are warm/moist → not affected)
Nerves commonly affected: Greater auricular, superficial peroneal, ulnar (most commonly affected nerve overall), posterior tibial, radial cutaneous, facial

Tuberculoid leprosy — large erythematous plaque with elevated border

Fig: Tuberculoid leprosy — Andrews' Diseases of the Skin

Lepromatous Leprosy (LL)

Numerous lesions, bilaterally symmetric
Macular → papular → nodular; coalesce → "leonine facies" (diffuse infiltration of face)
Skin thickening, loss of eyebrows (madarosis — loss of lateral eyebrows first) and eyelashes
Sensation relatively preserved early (but eventually lost due to diffuse nerve damage)
Symmetric peripheral neuropathy (unlike TT where asymmetric)
Nasal involvement: Chronic nasal congestion → saddle-nose deformity (septal perforation)
Testes: Orchitis → hyalinization → infertility, gynecomastia
Lymph nodes: Foamy macrophages in paracortex
Ocular: Corneal opacities ("iris pearls" = miliary lepromas of iris in BL/LL), lagophthalmos
Glove and stocking anesthesia — due to symmetric polyneuropathy
Lucio phenomenon: Specific to LL; hemorrhagic necrotic lesions (form of ENL in Lucio leprosy — diffuse non-nodular lepromatous leprosy in Mexico/Central America)

Fig: Lepromatous leprosy — Andrews' Diseases of the Skin (Courtesy: Shyam Verma)

Borderline Leprosy (BB)

Most unstable type on the spectrum
"Punched out" lesions with irregular, vague edges
Mixed features; may have satellite lesions
BB leprosy is the most difficult to classify
Liable to type 1 (reversal) reactions

Histoid Leprosy (Wade's histoid)

Variant of LL (downgraded/relapsed); classically seen in dapsone resistance or after irregular treatment
Well-defined, dome-shaped, shiny nodules (resembling dermatofibroma)
Bacilli in spindle-shaped histiocytes arranged in a storiform pattern
Highest bacterial index (BI) of all forms
Can occur over bony prominences (elbows, knees)

6. NERVE INVOLVEMENT — HIGH-YIELD TABLE

Nerve	Deformity/Feature
Ulnar nerve (most commonly enlarged/affected overall)	Claw hand (4th & 5th fingers); "Benediction sign" = inability to flex ring and little finger
Median nerve	Claw hand (index + middle fingers); "Ape hand" (thenar wasting)
Combined ulnar + median	Complete claw hand (all 4 fingers)
Radial nerve	Wrist drop, finger drop
Common peroneal (lateral popliteal)	Foot drop
Posterior tibial nerve	Plantar anesthesia, trophic ulcer, claw toes
Facial nerve (VII)	Lagophthalmos (inability to close eye) → exposure keratitis
Trigeminal nerve (V)	Corneal anesthesia → corneal ulcers
Greater auricular nerve	Visibly enlarged (tuberculoid/BT)
Radial cutaneous nerve	Enlarged at wrist (BT)

Memory Aid: Ulnar = most commonly affected nerve in leprosy. Lateral popliteal = most commonly affected lower limb nerve.

Claw hand types:

Ulnar claw = 4th & 5th fingers clawed (main-en-griffe)
Median claw = Index + middle fingers
Combined = all 4 fingers
"Benediction sign" (Pope's blessing) = ulnar nerve → cannot flex 4th & 5th = they remain extended when asked to make fist
"Ape hand" = median nerve → thenar wasting, thumb cannot oppose

7. HISTOPATHOLOGY

Feature	Tuberculoid (TT)	Lepromatous (LL)
Granuloma	Well-formed epithelioid granulomas with Langhans' giant cells; closely resemble TB	Absent; diffuse infiltrate
Infiltrating cells	Lymphocytes + epithelioid cells surrounding nerves and adnexae	Foamy macrophages (lepra cells / Virchow cells) filled with bacilli
Bacilli	Absent (paucibacillary)	Abundant; arranged in "globi" (cigar bundle pattern); "Mori bodies"
Subepidermal clear zone	Absent	Present (Grenz zone — clear zone between epidermis and infiltrate)
Nerve	Destroyed, enclosed in granuloma	Infiltrated by bacilli (Schwann cells); onion-skin perineural fibrosis
Stain	H&E (no bacilli visible)	Fite-Faraco stain (modified acid-fast) for bacilli; Ziehl-Neelsen for tissue

NEET Key — Grenz Zone: Pathognomonic of LL — normal collagen-free subepidermal zone between epidermis and the macrophage infiltrate.

Bacterial Index (BI) — Ridley's Logarithmic Scale

Score	AFB count per oil-immersion field
0	No AFB in 100 fields
1+	1–10 in 100 fields
2+	1–10 per 10 fields
3+	1–10 per field
4+	10–100 per field
5+	100–1000 per field
6+	>1000 per field (Histoid LL has highest BI)

Morphological Index (MI)

% of solid-staining (viable) bacilli in a smear
Normal = ~25–60% solid bacilli
After treatment: MI falls to 0 within 3–6 months (earlier than BI)
MI falls before BI — used to monitor early treatment response

8. LEPROMIN TEST (MITSUDA REACTION)

Not a diagnostic test — measures cell-mediated immunity (CMI)
Intradermal injection of autoclaved M. leprae suspension (Mitsuda antigen)

Reaction	Time	Interpretation
Fernandez reaction (early)	48–72 hours	Tuberculin-like; indicates prior exposure (type IV hypersensitivity)
Mitsuda reaction (late)	3–4 weeks	Granuloma formation; indicates good CMI; (+) in TT/BT, (−) in LL

Type	Lepromin Result
TT	Strongly positive (3+)
BT	Positive
BB	Weakly positive to negative
BL	Negative
LL	Strongly negative
Healthy population	Positive (~70%)
Normal newborns	Negative

Key: Lepromin positive = good prognosis; Lepromin negative = lepromatous/poor immunity. Diagnostic value = NIL.

9. LEPROSY REACTIONS (HIGH-YIELD)

These are acute immunological episodes that can occur before, during, or after treatment. Do NOT stop MDT during reactions.

Type 1 Reaction (Reversal Reaction — RR)

Feature	Detail
Mechanism	Type IV (delayed) hypersensitivity — sudden upregulation of CMI
Immunology	↑ IL-2, IFN-γ; CD4+ T cells
Spectrum	BT, BB, BL (borderline types — most unstable)
NOT in	TT or LL (stable poles)
Skin	Existing lesions become red, swollen, edematous, warm — "upgrading" or "downgrading"
Nerve	Acute neuritis — painful, tender nerves; sudden nerve function impairment
Systemic	No systemic features (fever, lymphadenopathy absent)
Timing	During/after MDT
Treatment	Systemic corticosteroids (prednisolone 40–60 mg/day) — tapered over 3–6 months

Type 2 Reaction — Erythema Nodosum Leprosum (ENL)

Feature	Detail
Mechanism	Type III (immune complex) hypersensitivity — antigen-antibody complex deposition
Immunology	↑ TNF-α, IL-6; complement activation; vasculitis
Spectrum	BL and LL only (multibacillary types with high antibody load)
Skin	Tender, erythematous nodules (new lesions, NOT existing ones) — on face, extensor limbs; may ulcerate
Systemic	Fever, malaise, lymphadenopathy, arthralgia, iridocyclitis, orchitis, nephritis — systemic features present
Timing	During/after MDT; 50% of LL patients experience ENL
Labs	Neutrophilia, elevated ESR, complement consumption
Treatment	Thalidomide (drug of choice; contraindicated in pregnancy — severe teratogen); Prednisolone; Clofazimine (↓ frequency/severity of ENL with long-term use)

Type 3 Reaction — Lucio Phenomenon

Specific to diffuse lepromatous (Lucio) leprosy in Mexico/Central America
Hemorrhagic, necrotic plaques → ulceration
Mechanism: immune complex vasculitis (similar to ENL but distinct)
NOT a classic type 1 or type 2 — considered a separate category

Comparison — Type 1 vs Type 2 Reaction (Most Tested)

Feature	Type 1 (RR)	Type 2 (ENL)
Mechanism	Type IV (cellular)	Type III (immune complex)
Spectrum	Borderline (BT/BB/BL)	LL and BL only
Skin lesions	Existing lesions — red/swollen	New tender nodules
Nerve involvement	Common; acute neuritis	May occur
Systemic symptoms	Absent	Present (fever, malaise)
Treatment	Prednisolone	Thalidomide
Histology	Lymphocytic infiltrate, edema	Neutrophilic infiltrate; vasculitis

10. MDT — MULTIDRUG THERAPY (WHO REGIMEN)

Adult PB Leprosy (≤5 lesions) — 6 months

Drug	Daily	Monthly (supervised)
Dapsone	100 mg daily (self)	—
Rifampicin	—	600 mg (supervised)

Adult MB Leprosy (>5 lesions) — 12 months

Drug	Daily	Monthly (supervised)
Dapsone	100 mg daily (self)	—
Clofazimine	50 mg daily (self)	300 mg (supervised)
Rifampicin	—	600 mg (supervised)

Pediatric MDT (10–14 years, weight-adjusted)

PB: Rifampicin 450 mg monthly + Dapsone 50 mg daily × 6 months
MB: Rifampicin 450 mg + Clofazimine 150 mg monthly; Dapsone 50 mg + Clofazimine 50 mg alternate days × 12 months
Clofazimine 6 mg/kg/month (supervised) for children

Single-Lesion PB Leprosy — ROM Regimen

Rifampicin 600 mg + Ofloxacin 400 mg + Minocycline 100 mg — single dose
Only for single skin lesion with no nerve involvement (not indeterminate)

Drug Mechanisms & Side Effects

Drug	MOA	Key Side Effects
Rifampicin	Inhibits RNA polymerase (bactericidal); most rapidly kills M. leprae	Orange urine, hepatotoxicity, drug interactions (CYP inducer)
Dapsone	Inhibits PABA incorporation (bacteriostatic)	Methemoglobinemia, hemolytic anemia (G6PD deficiency), dapsone hypersensitivity syndrome (DHS), agranulocytosis
Clofazimine	Binds DNA, also anti-inflammatory (anti-ENL effect)	Red-brown/bronze skin discoloration (reversible), ichthyosis, GI upset; not recommended in pregnancy

NEET Key: Rifampicin = most bactericidal drug in leprosy MDT. Clofazimine = reduces frequency/severity of ENL. Thalidomide = DOC for ENL but teratogenic.

11. DISABILITY GRADING (WHO)

Grade	Eyes	Hands	Feet
0	No problem	No problem	No problem
1	Visual impairment <6/60; insensitive cornea	Anaesthesia (no deformity)	Anaesthesia (no deformity)
2	Severe visual impairment ≥6/60 OR obvious deformity (lagophthalmos, iridocyclitis, corneal opacity)	Visible deformity or damage	Visible deformity or damage

NEET Key: Grade 2 disability = visible deformity. Grade 1 = only anesthesia/impairment without visible deformity.

12. DIAGNOSIS OF LEPROSY

Clinical Diagnosis (WHO Criteria — 3 Cardinal Signs)

Hypopigmented/erythematous skin lesion with loss of sensation
Thickened peripheral nerve with sensory/motor loss
Positive skin smear for AFB

1 or more cardinal signs → diagnosis of leprosy

Investigations

Test	Use
Slit skin smear	Sample from earlobe, forehead, chin, active lesion; Fite-Faraco stained; calculates BI + MI
Skin biopsy	Confirms histological type; most important for diagnosis; done at lesion edge
Lepromin test	Not diagnostic; measures CMI
PCR	Detects M. leprae DNA; useful for indeterminate/pure neural leprosy; can detect drug resistance
Serology (anti-PGL-1 IgM)	Elevated in MB leprosy; useful for monitoring relapse
Nerve conduction study	Assesses nerve damage
Nerve biopsy	Sural nerve; for pure neural leprosy

Sensory Testing Sequence (First to Last affected)

Temperature (cold sensation — FIRST to be lost)
Light touch
Pain (pin prick)
Deep pressure (last to be lost)

NEET Key: Temperature sensation is the FIRST to be lost in leprosy.

13. SPECIAL FORMS & ASSOCIATIONS

Pure Neural Leprosy

Only nerve involvement, no skin lesions
Can be TT, BT, or LL type
Constitutes up to 5% of cases in Nepal/India
Diagnosis: Nerve biopsy (sural nerve most commonly biopsied)

Leprosy in Children

Indeterminate form most common
Tuberculoid most common type overall in children
BCG vaccination offers partial protection

Leprosy and Pregnancy

Type 1 and type 2 reactions ↑ during pregnancy and postpartum
Clofazimine: relatively contraindicated (crosses placenta → neonatal skin discoloration)
Thalidomide: absolutely contraindicated in pregnancy
MDT (rifampicin + dapsone) — safe in pregnancy

Leprosy and HIV

HIV does not dramatically increase risk of leprosy
Can cause immune reconstitution inflammatory syndrome (IRIS) → type 1 reactions after ART
HIV + leprosy = more unusual presentations

14. VACCINES IN LEPROSY

Vaccine	Detail
BCG	~50% protection; children benefit most; revaccination may increase protection
MIP (Mw vaccine)	Mycobacterium indicus pranii; developed at JALMA, Agra (ICMR); immunoprophylactic + immunotherapeutic; used as adjuvant with MDT
LepVax	Novel subunit vaccine in trials

NEET Key: MIP vaccine = developed in India (JALMA, Agra/Delhi — answer varies by source; JALMA is in Agra); used as adjunct in MB leprosy. BCG gives partial protection.

15. OCULAR, NASAL & SYSTEMIC INVOLVEMENT

Ocular (Lepromatous)

Lagophthalmos (VII nerve) → exposure keratitis
Corneal anesthesia (V nerve) → corneal ulcers
Iris pearls (miliary lepromas of iris) — in BL/LL
Corneal opacities, avascular keratitis, pannus formation
Iridocyclitis (in ENL reactions)

Nasal

Chronic nasal congestion → epistaxis
Septal perforation → saddle-nose deformity
Loss of upper incisor teeth (from alveolar infiltration in LL)

Testes

Orchitis → destruction of seminiferous tubules → azoospermia, infertility, gynecomastia (LL)

Kidney

ENL → immune complex glomerulonephritis (mesangial)

16. LEPROSY — KEY MNEMONICS

Mnemonic	Fact
"Ulnar is the MOST common nerve"	Ulnar = most frequently affected nerve in leprosy (elbow level)
"Temperature FIRST"	First sensation lost = cold/temperature
"ENL = EVERYTHING (systemic)"	Type 2 = fever, lymphadenopathy, iritis, orchitis
"Reversal = Reversal of CMI (Borders go up)"	Type 1 = borderline spectrum; no systemic features
"Thalidomide for ENL, Prednisolone for RR"	Treatment distinction
"Grenz zone = LL"	Subepidermal clear zone in lepromatous leprosy
"BI falls slowly, MI falls fast"	MI → 0 in 3–6 months; BI takes years
"Histoid = Highest BI"	Wade's histoid leprosy
"6P in PB, 12P in MB"	6 months PB; 12 months MB

17. PREVIOUS YEAR QUESTIONS (PYQ) — NEET PG / INI-CET / AIPGMEE

🔴 PYQ BLOCK 1 — Bacteriology & Immunology

Q1. [NEET PG / AIPGMEE] The doubling time of M. leprae is:

A. 24 hours
B. 6 days
C. 13 days ✅
D. 30 days

Explanation: M. leprae replicates every 13 days — slowest of all bacteria. This explains the long incubation period (2–12 years).

Q2. [AIPGMEE] Lepromin test is positive in all EXCEPT:

A. Tuberculoid leprosy
B. Normal adults
C. Sarcoidosis
D. Lepromatous leprosy ✅

Explanation: Lepromin measures CMI. LL has defective CMI → strongly negative. TT, normal adults, sarcoidosis, and BCG-vaccinated individuals are lepromin positive.

Q3. Which of the following correctly describes the lepromin test?

A. It is diagnostic of leprosy
B. It requires a live bacillus suspension
C. It measures cell-mediated immunity ✅
D. Mitsuda reaction is read at 48–72 hours

Explanation: Lepromin measures CMI, not diagnostic. Mitsuda reaction = 3–4 weeks (granuloma). Fernandez = 48–72 hours (early reaction).

Q4. [INICET] BCG vaccination provides protection against leprosy by:

A. Producing anti-PGL-1 antibodies
B. Activating Th2 cells
C. Cross-reactive CMI against M. leprae ✅
D. Directly neutralizing M. leprae

🔴 PYQ BLOCK 2 — Classification & Histology

Q5. [NEET PG] According to WHO classification, paucibacillary leprosy includes:

A. ≤3 lesions only
B. Single lesion only
C. ≤5 lesions with negative smear ✅
D. >5 lesions with negative smear

Explanation: WHO PB = ≤5 skin lesions + smear negative. MB = >5 lesions OR smear positive.

Q6. [AIPGMEE 2017] The most characteristic histological feature of lepromatous leprosy is:

A. Epithelioid granuloma
B. Caseous necrosis
C. Foamy macrophages (lepra/Virchow cells) with globi ✅
D. Neutrophilic microabscesses

Explanation: LL = foamy macrophages (lepra cells) packed with AFB arranged in globi. Grenz zone is also characteristic.

Q7. [AIPGMEE] Grenz zone is seen in:

A. Tuberculoid leprosy
B. Borderline leprosy
C. Lepromatous leprosy ✅
D. Indeterminate leprosy

Explanation: Grenz zone = subepidermal clear zone in LL — uninvaded subepidermal band of collagen separating epidermis from the macrophage infiltrate.

Q8. [NEET PG / INI-CET] Histoid leprosy is characterized by all EXCEPT:

A. Well-defined shiny nodules
B. Seen in previously untreated patients ✅ (Incorrect — seen in dapsone-resistant/relapsed patients)
C. High bacterial index
D. Spindle-shaped histiocytes in storiform pattern

Explanation: Histoid leprosy occurs in dapsone resistance or irregular treatment (not untreated). It has the highest BI of all forms.

Q9. What is the most unstable form in the leprosy spectrum?

A. TT
B. BB (mid-borderline) ✅
C. BT
D. LL

Explanation: BB is the most immunologically unstable — prone to upgrading (toward TT) or downgrading (toward LL) reactions.

🔴 PYQ BLOCK 3 — Clinical Features & Nerve Involvement

Q10. [AIPGMEE / NEET PG] The most commonly enlarged nerve in leprosy is:

A. Posterior tibial nerve
B. Ulnar nerve ✅
C. Greater auricular nerve
D. Facial nerve

Explanation: Ulnar nerve (at the elbow) is the most commonly involved nerve. It is also the most superficial peripheral nerve — vulnerable to thickening.

Q11. [NEET PG] "Benediction sign" (Pope's sign) in leprosy is due to involvement of:

A. Radial nerve
B. Ulnar nerve ✅
C. Median nerve
D. Peroneal nerve

Explanation: Ulnar nerve palsy → inability to flex 4th and 5th digits → they remain extended = Benediction/Pope's blessing sign.

Q12. [INICET] Foot drop in leprosy is due to involvement of:

A. Posterior tibial nerve
B. Femoral nerve
C. Common peroneal (lateral popliteal) nerve ✅
D. Sural nerve

Q13. [NEET PG 2023] A patient presents with a hypopigmented anesthetic patch on the trunk. The first sensation to be lost in leprosy is:

A. Fine touch
B. Pain
C. Temperature (cold) ✅
D. Deep pressure

Explanation: Sequence of sensory loss in leprosy: Temperature → Light touch → Pain → Deep pressure. Temperature (especially cold) is FIRST.

Q14. [AIPGMEE] The feeding nerve in leprosy (nerve visibly running into a skin lesion) is characteristically seen in:

A. LL leprosy
B. Indeterminate leprosy
C. BT (borderline tuberculoid) leprosy ✅
D. BB leprosy

Explanation: "Feeding nerve" = enlarged nerve trunk leading into the skin lesion, most characteristic of BT leprosy.

Q15. [NEET PG] Saddle-nose deformity in leprosy results from:

A. Traumatic septal fracture
B. Granulomatous infiltration of nasal septum (LL) ✅
C. Type 1 reaction
D. ENL

Explanation: In LL — nasal mucosa infiltration → septal perforation → saddle-nose deformity.

🔴 PYQ BLOCK 4 — Reactions

Q16. [NEET PG / AIPGMEE] Type 1 reaction (reversal reaction) in leprosy is seen in:

A. TT leprosy only
B. LL leprosy only
C. Borderline spectrum (BT, BB, BL) ✅
D. All forms of leprosy

Explanation: Type 1 reactions occur in borderline spectrum (BT/BB/BL). TT and LL are stable poles and do NOT develop reversal reactions.

Q17. [NEET PG 2022/2023] Erythema Nodosum Leprosum (ENL) is:

A. Type I hypersensitivity
B. Type III (immune complex) hypersensitivity ✅
C. Type IV hypersensitivity
D. Type II hypersensitivity

Explanation: ENL = immune complex deposition → complement activation → neutrophil infiltration → vasculitis. Type III reaction.

Q18. [AIPGMEE] Drug of choice for ENL (Erythema Nodosum Leprosum) is:

A. Prednisolone
B. Clofazimine
C. Thalidomide ✅
D. Dapsone

Explanation: Thalidomide is DOC for ENL. MOA: ↓ TNF-α. CONTRAINDICATED in pregnancy (phocomelia). Prednisolone used when thalidomide unavailable or in women of childbearing age.

Q19. [INICET] During type 1 reaction in leprosy, which of the following is TRUE?

A. New lesions appear
B. Systemic features like fever are common
C. Existing lesions become erythematous and edematous ✅
D. Immune complexes are deposited in vessel walls

Explanation: Type 1 (RR) — existing lesions flare up; no new lesions; no systemic features. Mechanism = CMI upregulation (Type IV).

Q20. [NEET PG] Lucio phenomenon is seen in:

A. Borderline leprosy
B. Tuberculoid leprosy
C. ENL patients in India
D. Diffuse lepromatous leprosy (Lucio leprosy) — mainly Mexico/Central America ✅

🔴 PYQ BLOCK 5 — Treatment

Q21. [NEET PG 2024] WHO-recommended treatment for multibacillary leprosy in adults:

A. Rifampicin + Dapsone × 12 months
B. Rifampicin + Dapsone + Clofazimine × 12 months ✅
C. Rifampicin + Clofazimine × 6 months
D. Rifampicin + Dapsone × 6 months

Q22. [AIPGMEE] Which drug causes red-brown skin discoloration in leprosy treatment?

A. Dapsone
B. Rifampicin
C. Clofazimine ✅
D. Minocycline

Explanation: Clofazimine → reddish-brown/bronze skin discoloration (reversible on stopping). Also causes ichthyosis and GI side effects.

Q23. [NEET PG] Dapsone causes all of the following EXCEPT:

A. Methemoglobinemia
B. Hemolytic anemia in G6PD deficiency
C. Hepatocellular carcinoma ✅ (Not a known effect)
D. Agranulocytosis

Q24. [INICET] ROM regimen in leprosy consists of:

A. Rifampicin, Ofloxacin, Metronidazole
B. Rifampicin, Ofloxacin, Minocycline — single dose ✅
C. Rifampicin, Ofloxacin, Moxifloxacin
D. Rifampicin, Ofloxacin, Minocycline × 6 months

Explanation: ROM = single-dose treatment for single lesion PB leprosy only.

Q25. [NEET PG 2025 Recall] A young patient presents with non-progressive hypopigmented lesion on trunk. Wood's lamp shows white accentuation. Diascopy is negative. Most likely diagnosis:

A. Vitiligo
B. Nevus depigmentosus ✅ (Note: Some sources say indeterminate leprosy — the KEY differentiator is white accentuation on Wood's lamp WITHOUT complete depigmentation)
C. Nevus anemicus
D. Indeterminate leprosy

Explanation: Vitiligo = chalky-white/brilliant fluorescence. Nevus depigmentosus = hypopigmented (not depigmented); white accentuation (but not chalk-white). Diascopy negative rules out vascular lesion. Indeterminate leprosy would show anesthesia within the lesion.

🔴 PYQ BLOCK 6 — Miscellaneous

Q26. [AIPGMEE] Morphological Index (MI) in leprosy smear indicates:

A. Number of bacilli per field
B. Percentage of solid (viable) bacilli ✅
C. Granuloma density
D. Nerve damage extent

Explanation: MI = % of solidly staining bacilli (viable). Falls to 0 first (3–6 months) → best early indicator of therapeutic response.

Q27. [NEET PG] In WHO disability grading of leprosy, Grade 1 for hands means:

A. Visible deformity or damage
B. Claw hand
C. Anesthesia of the palm (no visible deformity) ✅
D. Loss of digits

Q28. [INICET] MIP vaccine for leprosy was developed at:

A. NIMHANS, Bangalore
B. JALMA, Agra (ICMR) ✅
C. AIIMS, New Delhi
D. CMC, Vellore

Q29. [AIPGMEE] Clofazimine in leprosy acts by:

A. Inhibiting RNA polymerase
B. Inhibiting PABA synthesis
C. Binding to mycobacterial DNA + anti-inflammatory effect ✅
D. Inhibiting cell wall synthesis

Q30. [NEET PG] All are true about lepromatous leprosy EXCEPT:

A. Symmetric skin lesions
B. Leonine facies
C. Lepromin test positive ✅
D. Highest bacterial index

Explanation: Lepromin is NEGATIVE in LL. All other options are true for LL.

RAPID REVISION TABLE — NEET PG FAVOURITE COMPARISONS

Feature	Tuberculoid (TT)	Lepromatous (LL)
Lesion count	1–3 (few)	Numerous
Symmetry	Asymmetric	Symmetric
Sensation in lesion	Anesthetic	Reduced/normal early
Lepromin test	Strongly +ve	Strongly −ve
Bacilli in smear	0 (PB)	+++ (MB)
Granuloma	Well-formed	Absent
Histology	Epithelioid granuloma	Lepra cells + Globi
CMI	High (Th1)	Low (Th2)
Prognosis	Good	Poor (without treatment)
Nerve damage	Early, asymmetric	Late, symmetric
Communicability	Low	High
Reactions	Type 1 (if BT)	Type 2 (ENL)

Sources: Andrews' Diseases of the Skin – Clinical Dermatology | Robbins, Cotran & Kumar – Pathologic Basis of Disease 10e | Roitt's Essential Immunology | Indian Journal of Postgraduate Dermatology (Leprosy Quiz, 2024)

This covers the complete syllabus for Hansen's disease as tested in NEET PG and INI-CET. Key high-frequency exam areas:

Ridley-Jopling vs WHO classification — lesion counts, smear status
Type 1 vs Type 2 reactions — mechanism, spectrum, treatment
Nerve involvement table — ulnar (most common), peroneal (foot drop), facial (lagophthalmos)
MDT regimens — 6 months PB vs 12 months MB; ROM single dose
Lepromin test — not diagnostic; Mitsuda reaction at 3–4 weeks
Histology — epithelioid granuloma (TT) vs foamy lepra cells + Grenz zone (LL)
Thalidomide for ENL; Prednisolone for Type 1/RR
First sensation lost = Temperature (cold)

Help me revise the topics for neet pg and inicet exam in fast way based on the image I provide which should be included in one page all the matter should exactly be the same without adding anything or from outer sources make it as a aesthetic style notes

It looks like you'd like to share an image with me so I can convert its content into aesthetic one-page revision notes — but I don't see any image attached to your message yet!

Could you please upload the image (photo of your notes, a screenshot, or a textbook page)? Once I can see it, I'll:

Extract all the content exactly as written — no additions from outside sources
Reformat it into beautiful, aesthetic one-page revision notes styled for quick NEET PG / INI-CET revision

Please go ahead and share the image!

This is a shared conversation. Sign in to Orris to start your own chat.